NAVITAS and ENVISION
Pain, Chronic
About this trial
This is an interventional treatment trial for Pain, Chronic
Eligibility Criteria
Key Inclusion Criteria:
- Is willing and able to comply with completing protocol required assessments and evaluations
Key Exclusion Criteria:
- Has any pain-related diagnosis, medical/psychological condition or external factors that, in the investigator's medical judgment, might confound reporting of study outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in litigation, workmen's compensation)
Sites / Locations
- Hope Research Institute
- Banner University Medical CenterRecruiting
- Coastal Research InstituteRecruiting
- South Lake Pain Institute, IncRecruiting
- University of Florida Shands HospitalRecruiting
- Tallahassee Neurological Clinic, PARecruiting
- Ochsner Clinic FoundationRecruiting
- Willis-Knighton River Cities Clinical Research CenterRecruiting
- Forest Health Medical CenterRecruiting
- KC Pain CentersRecruiting
- The Center for Clinical Research, LLCRecruiting
- Pacific Sports and Spine, LLCRecruiting
- PCPMG Clinical Research Unit, LLC
- Precision Spine Care
- Washington Center for Pain Management
- EvergreenHealth Pain Care
- Advanced Pain Management Appleton
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
De Novo Cohort
Existing Cohort
Study subjects who have not previously attempted a Neurostimulator trial will be followed up to 36 months post-Neurostimulation trial procedure or IPG Activation on the use of their Neurostimulation system.
Study subjects who have completed permanent neurostimulator IPG implant and are in various stages of follow-up will be followed up to 36 months post-Neurostimulation trial or IPG Activation procedure on the use of their Neurostimulation system.